Preliminary results of phase I clinical trial of high doses of seleno-L-methionine (SLM) in sequential combination with axitinib in previously treated and relapsed clear cell renal cell carcinoma (ccRCC) patients.

Rohan Garje, Yousef Zakharia, Kenneth G. Nepple et al.|Journal of Clinical Oncology|2019

Cited by 5